Trial
NCT01012999
A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
—
Condition
Pain
Intervention
sufentanil
Why stopped
Difficulty enrolling patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-22